Pharmacokinetics and Pharmacodynamics of the Nonvitamin K Antagonist Oral Anticoagulant Edoxaban When Administered Alone or After Switching from Rivaroxaban or Dabigatran Etexilate...

Por Parasrampuria, Dolly A., Weilert, Doris, Maa, Jen-Fue, Dishy, Victor, Kochan, Jarema, Shi, Minggao, Brown, Karen S.
Publicado no Clin Drug Investig (2015)

Sildenafil does not improve nitric oxide-mediated endothelium-dependent vascular responses in smokers

Por Dishy, Victor, Harris, Paul A, Pierce, Rosanna, Prasad, Harish C, Sofowora, Gbenga, Bonar, Holly L, Wood, Alastair J J, Stein, C Michael
Publicado em 2004

Endothelial Function in Systemic Lupus Erythematosus: Relationship to Disease Activity, Cardiovascular Risk Factors, Corticosteroid Therapy, and Coronary Calcification

Por Turner, Elizabeth, Dishy, Victor, Chung, Cecilia P, Harris, Paul, Pierce, Rosanna, Asanuma, Yu, Oeser, Annette, Gebretsadik, Tebeb, Shintani, Ayumi, Raggi, Paolo, Stein, C Michael
Publicado em 2005

Pharmacokinetics and Pharmacodynamics of MK-5046, a Bombesin Receptor Subtype-3 (BRS-3) Agonist, in Healthy Patients

Por Reitman, Marc L., Dishy, Victor, Moreau, Allison, Denney, William S., Liu, Chengcheng, Kraft, Walter K., Mejia, Alex V., Matson, Mark A., Stoch, S. Aubrey, Wagner, John A., Lai, Eseng
Publicado no J Clin Pharmacol (2011)